Home LiteratureArticle Details
PMID: 2309707 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1).

American journal of human genetics ·Vol. 46 ·No. 3 ·1990-03-00 ·Pages 591-601

Cohn DH, Starman BJ, Blumberg B, Byers PH

Abstract

We have determined that two infants with perinatal lethal osteogenesis imperfecta in one family had the same new dominant point mutation. Although not detected in his dermal fibroblast DNA, the mutation was detected in somatic DNA from the father's hair root bulbs and lymphocytes. The mutation was also detected in the father's sperm, demonstrating that mosaicism in the father's germ line explains recurrence. The presence of both germ-line and somatic mosaicism indicates that the mutation occurred prior to segregation of the germ-line and somatic cell progenitors. About one in eight sperm carry the mutation, which implies that at least four progenitor cells populate the germ line in human males. The observation that the mosaic individual is clinically normal suggests that genetic diseases can have both qualitative and quantitative components.

MeSH Terms
Base Sequence Collagen/genetics DNA/genetics Female Genes, Dominant Humans Infant, Newborn Male Molecular Sequence Data Mosaicism Mutation Oligonucleotide Probes Osteogenesis Imperfecta/genetics Pedigree Polymerase Chain Reaction Pregnancy
Chemicals
Oligonucleotide Probes Collagen DNA
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Cohn D H
Division of Medical Genetics, Cedars-Sinai Medical Center, Los Angeles.
Starman B J
Blumberg B
Byers P H
References (36)
36 references, click to expand
  1. Dominant ectrodactyly and possible germinal mosaicism.
    J Med Genet. 1972 Sep;9(3):316-20 PMID: 5079103
  2. Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta.
    J Biol Chem. 1988 Jun 15;263(17):8398-404 PMID: 3372533
  3. Gene control of mammalian differentiation.
    Annu Rev Genet. 1974;8:411-70 PMID: 4613263
  4. Detection of specific sequences among DNA fragments separated by gel electrophoresis.
    J Mol Biol. 1975 Nov 5;98(3):503-17 PMID: 1195397
  5. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.
    Proc Natl Acad Sci U S A. 1975 Oct;72(10):3961-5 PMID: 1105573
  6. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  7. Periodic hypokalemic paralysis transmitted by an unaffected male with negative family history: a delayed mutation?
    Hum Genet. 1979 Apr 17;48(1):113-6 PMID: 457125
  8. In vitro packaging of lambda Dam vectors and their use in cloning DNA fragments.
    Methods Enzymol. 1979;68:281-98 PMID: 232217
  9. Possible gonadal mosaicism in a family with hemoglobin Köln.
    Johns Hopkins Med J. 1980 Jun;146(6):236-40 PMID: 7382247
  10. Two-dimensional CNBr peptide patterns of collagen types I, II and III.
    Coll Relat Res. 1981;1(1):17-26 PMID: 7346218
  11. Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants.
    Gene. 1982 Jun;18(3):289-96 PMID: 6290332
  12. Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.
    J Biol Chem. 1983 Jun 25;258(12):7721-8 PMID: 6863261
  13. X-chromosome inactivation mosaicism in the three germ layers and the germ line of the mouse embryo.
    J Embryol Exp Morphol. 1983 Apr;74:207-20 PMID: 6886595
  14. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity.
    Am J Med Genet. 1984 Feb;17(2):407-23 PMID: 6702894
  15. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.
    Anal Biochem. 1984 Feb;137(1):266-7 PMID: 6329026
  16. DNA and chromatin structure of the human alpha 1 (I) collagen gene.
    J Biol Chem. 1984 Dec 10;259(23):14906-13 PMID: 6094581
  17. Multiexon deletion in an osteogenesis imperfecta variant with increased type III collagen mRNA.
    J Biol Chem. 1985 Jan 25;260(2):691-4 PMID: 2981843
  18. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.
    J Biol Chem. 1985 Feb 10;260(3):1734-42 PMID: 2981871
  19. Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta.
    Proc Natl Acad Sci U S A. 1985 May;82(9):2870-4 PMID: 3857621
  20. Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
    Nature. 1985 Jul 25-31;316(6026):363-6 PMID: 4022126
  21. Retroviruses as probes for mammalian development: allocation of cells to the somatic and germ cell lineages.
    Cell. 1986 Jul 4;46(1):19-29 PMID: 3013418
  22. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.
    Proc Natl Acad Sci U S A. 1986 Aug;83(16):6045-7 PMID: 3016737
  23. Germinal mosaicism in Apert syndrome.
    Clin Genet. 1986 May;29(5):429-33 PMID: 3742849
  24. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy.
    Hum Genet. 1987 Mar;75(3):221-7 PMID: 2881877
  25. Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.
    J Biol Chem. 1987 May 25;262(15):7021-7 PMID: 3108247
  26. Osteogenesis imperfecta type IIA: evidence for dominant inheritance.
    J Med Genet. 1987 Jul;24(7):386-9 PMID: 3612714
  27. Germline mosaicism and Duchenne muscular dystrophy mutations.
    Nature. 1987 Oct 8-14;329(6139):554-6 PMID: 2889144
  28. A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male.
    Nature. 1987 Oct 8-14;329(6139):556-8 PMID: 2889145
  29. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
    J Biol Chem. 1987 Oct 25;262(30):14737-44 PMID: 3667599
  30. Gonadal mosaicism in pseudoachondroplasia.
    Am J Med Genet. 1987 Sep;28(1):143-51 PMID: 3314506
  31. Genetic counselling in unexpected familial recurrence of achondroplasia.
    Am J Med Genet. 1987 Dec;28(4):949-54 PMID: 3688033
  32. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  33. Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.
    Am J Hum Genet. 1988 Feb;42(2):237-48 PMID: 3341380
  34. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Nature. 1988 Mar 10;332(6160):131-6 PMID: 2450280
  35. A novel mutation causes a perinatal lethal form of osteogenesis imperfecta. An insertion in one alpha 1(I) collagen allele (COL1A1).
    J Biol Chem. 1988 Jun 5;263(16):7855-61 PMID: 3372508
  36. Primordial cell pool size and lineage relationships of five human cell types.
    Ann Hum Genet. 1973 Jul;37(1):39-48 PMID: 4759903
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
1990-03-00
Pages
591-601
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1683617
Subset
IM
Grants
NIAMS NIH HHS · AR07713 · United States
NIAMS NIH HHS · AR21557 · United States
NIGMS NIH HHS · GM15253 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]